| Literature DB >> 31366105 |
Xican Li1,2, Xiaojian Ouyang3,4, Minshi Liang3,4, Dongfeng Chen5,6.
Abstract
The biological process,Entities:
Keywords: 3-O-galactosylation; antioxidant pathway; myricetin; myricetin-3-O-galactoside; radical adduct formation
Year: 2019 PMID: 31366105 PMCID: PMC6696482 DOI: 10.3390/molecules24152769
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Structures of myricetin-3-O-galactoside (M3OGa) (A) and myricetin (B).
Figure 2Typical results of the UPLC-ESI-Q-TOF-MS analysis: (A) Chromatogram of myricetin-3-O-galactoside (M3OGa) when the formula, [C21H20O13-H]−, was extracted; (B) primary MS spectra of M3OGa; (C) secondary MS spectra of M3OGa; (D) chromatogram of the radical adduct formation (RAF) product of M3OGa–DPPH when the formula, [C39H31N5O19-H]−, was extracted; (E) primary MS spectra of the RAF product of M3OGa–DPPH; (F) secondary MS spectra of the RAF product of M3OGa–DPPH; (G) chromatogram of possible dimeric products of M3OGa when the formula, [C42H38O26-H]−, was extracted; (H) primary MS spectra of possible dimeric products of M3OGa; (I) secondary MS spectra of the RAF product of the dimeric products of M3OGa; (J) chromatogram of myricetin when the formula, [C15H10O8-H]−, was extracted; (K) primary MS spectra of myricetin; (L) secondary MS spectra of myricetin; (M) chromatogram of the RAF product of myricetin–DPPH when the formula, [C33H21N5O14-H]−, was extracted; (N) primary MS spectra of the RAF product of myricetin–DPPH; (O) secondary MS spectra of the RAF product of myricetin–DPPH; (P) chromatogram of possible dimeric products of M3OGa when the formula, [C30H18O16-H]−, was extracted; (Q) primary MS spectra of possible dimeric products of myricetin; (R) secondary MS spectra of the RAF product of the dimeric products of myricetin.
Figure 3Proposed MS elucidations of the RAF reaction products between M3OGa and the DPPH• radical. (A) M3OGa–DPPH adduct; (B) M3OGa–M3OGa dimer (the MS spectra were in the negative ion mode. The accurate m/z values are simply expressed as integers. Other linking sites between the M3OGa and DPPH moieties and other reasonable cleavages should not be excluded in the MS elucidation).
Figure 4Proposed MS elucidations of the RAF reaction products between myricetin and the DPPH• radical. (A) Myricetin–DPPH adduct; (B) myricetin–myricetin dimer (the MS spectra were in the negative ion mode. The circle indicates σ bond rotation. The accurate m/z values are simply expressed as integers. Other linking sites between the myricetin and DPPH moieties and other reasonable cleavages should not be excluded in the MS elucidation).
Figure 5Proposed chain reaction of M3OGa trapping 2 mol DPPH•.
IC50 values (μM) of M3OGa and myricetin in the antioxidant spectrophotometric analyses.
| Antioxidant Analyses | M3OGa | Myricetin | Trolox |
|---|---|---|---|
| DPPH•-trapping | 12.9 ± 0.3 b | 10.7 ± 0.3 a | 26.4 ± 2.5 |
| PTIO•-trapping (pH 4.5) | 263.7 ± 3.5 b | 132.9 ± 5.1 a | 220.1 ± 4.6 |
| PTIO•-trapping (pH 7.4) | 131.2 ± 5.1 b | 81.5 ± 2.4 a | 142.9 ± 5.0 |
| •O2−-trapping | 88.9 ± 7.2 b | 73.3 ± 1.9 a | 2777.5 ± 35.3 |
The IC50 value (in μM) was defined as the final concentration of 50% radical inhibition or relative reducing power, determined by linear regression analysis and expressed as the mean ± SD (n = 3). The linear regression was analyzed using version 6.0 of the Origin professional software. The IC50 values with different superscripts (a or b), between M3OGa and myricetin, are significantly different (p < 0. 05). Trolox is the positive control. The dose response curves are listed in Supplementary File S3, Figures S1–S4.
Figure 6Preferential conformations of myricetin-3-O-galactoside (M3OGa) and myricetin. (A) Front view of M3OGa; (B) front view of myricetin; (C) right side view of M3OGa; (D) right side view of myricetin. The preferential conformation was analyzed using the Chem3D Pro14.0 program (PerkinElmer, Waltham, MA, USA).